Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders.

Anyuan Zhang, Qiubai Li, Zhichao Chen
Author Information
  1. Anyuan Zhang: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  2. Qiubai Li: Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. ORCID
  3. Zhichao Chen: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. ORCID

Abstract

The global issue of aging populations has become increasingly prominent, thus the research and development for anti-aging therapies to assure longevity as well as to ameliorate age-related complications is put high on the agenda. The young humoral milieu has been substantiated to impart youthful characteristics to aged cells or organs. Extracellular vesicles (EVs) are a heterogeneous group of cell-derived membrane-limited structures that serve as couriers of proteins and genetic material to regulate intercellular communication. Of note, EVs appeared to be an indispensable component of young blood in prolonging lifespans, and circulating EVs have been indicated to mediate the beneficial effect of a young milieu on aging. Human umbilical cord mesenchymal stem cell-derived EVs (HUCMSC-EVs), isolated from the youngest adult stem cell source, are speculated to reproduce the function of circulating EVs in young blood and partially revitalize numerous organs in old animals. Robust evidence has suggested HUCMSC-EVs as muti-target therapeutic agents in combating aging and alleviating age-related degenerative disorders. Here, we provide a comprehensive overview of the anti-aging effects of HUCMSC-EVs in brain, heart, vasculature, kidney, muscle, bone, and other organs. Furthermore, we critically discuss the current investigation on engineering strategies of HUCMSC-EVs, intending to unveil their full potential in the field of anti-aging research.

Keywords

References

  1. Nat Aging. 2024 Jun;4(6):814-838 [PMID: 38627524]
  2. Acta Biomater. 2020 Feb;103:196-212 [PMID: 31857259]
  3. Theranostics. 2020 Jan 16;10(5):2293-2308 [PMID: 32089743]
  4. ACS Nano. 2021 Nov 23;15(11):17439-17452 [PMID: 34677951]
  5. Signal Transduct Target Ther. 2023 Mar 14;8(1):114 [PMID: 36918543]
  6. Nano Converg. 2022 Dec 19;9(1):57 [PMID: 36534191]
  7. Immunol Invest. 2022 Aug;51(6):1785-1803 [PMID: 35332841]
  8. Cell Mol Biol Lett. 2023 Feb 7;28(1):12 [PMID: 36750776]
  9. Stem Cell Res Ther. 2022 Jun 3;13(1):226 [PMID: 35659361]
  10. Neurochem Res. 2021 Mar;46(3):455-467 [PMID: 33258087]
  11. Bone. 2019 Feb;119:1-7 [PMID: 30010082]
  12. Stem Cells. 2024 May 15;42(5):460-474 [PMID: 38381592]
  13. Int J Mol Sci. 2022 Sep 09;23(18): [PMID: 36142334]
  14. J Neurosci. 2017 Oct 25;37(43):10334-10345 [PMID: 28931572]
  15. J Ovarian Res. 2024 Nov 14;17(1):224 [PMID: 39543679]
  16. J Neuroinflammation. 2022 Apr 6;19(1):80 [PMID: 35387668]
  17. Lancet. 2015 Jul 25;386(9991):376-87 [PMID: 25748615]
  18. Regen Ther. 2022 Aug 28;21:282-287 [PMID: 36092501]
  19. Free Radic Biol Med. 2022 Nov 20;193(Pt 1):108-121 [PMID: 36241072]
  20. J Extracell Vesicles. 2022 Jun;11(6):e12235 [PMID: 35716062]
  21. Cell Metab. 2019 Aug 6;30(2):329-342.e5 [PMID: 31204283]
  22. Sci Adv. 2024 Apr 5;10(14):eadl3406 [PMID: 38569030]
  23. Mol Ther. 2023 May 3;31(5):1231-1250 [PMID: 36805147]
  24. Int J Biol Sci. 2024 Jun 17;20(9):3515-3529 [PMID: 38993565]
  25. Adv Sci (Weinh). 2020 Aug 20;7(18):1903746 [PMID: 32999825]
  26. Sci China Life Sci. 2023 May;66(5):893-1066 [PMID: 37076725]
  27. J Orthop Translat. 2020 Apr 23;23:21-28 [PMID: 32455113]
  28. NPJ Regen Med. 2024 Jan 13;9(1):3 [PMID: 38218925]
  29. Theranostics. 2020 May 18;10(15):6728-6742 [PMID: 32550900]
  30. Neurochem Res. 2018 Nov;43(11):2165-2177 [PMID: 30259257]
  31. Nature. 2022 Mar;603(7900):309-314 [PMID: 35236985]
  32. J Extracell Vesicles. 2021 Oct;10(12):e12154 [PMID: 34609061]
  33. Cell. 2013 Jun 6;153(6):1194-217 [PMID: 23746838]
  34. Am J Transl Res. 2020 Sep 15;12(9):4998-5014 [PMID: 33042402]
  35. Stem Cell Res Ther. 2020 Aug 3;11(1):336 [PMID: 32746936]
  36. Bioact Mater. 2023 Aug 04;30:169-183 [PMID: 37593145]
  37. Stem Cell Res Ther. 2020 Jul 8;11(1):273 [PMID: 32641103]
  38. Cell Prolif. 2019 Mar;52(2):e12570 [PMID: 30663158]
  39. Hum Cell. 2022 Jan;35(1):83-97 [PMID: 34585365]
  40. Stem Cells. 2020 Sep;38(9):1137-1148 [PMID: 32442343]
  41. Front Cell Dev Biol. 2024 Oct 16;12:1469541 [PMID: 39479514]
  42. Theranostics. 2022 Oct 31;12(17):7550-7566 [PMID: 36438474]
  43. Cell Death Dis. 2023 May 12;14(5):321 [PMID: 37173309]
  44. Tissue Eng Regen Med. 2020 Apr;17(2):155-163 [PMID: 32026314]
  45. J Extracell Vesicles. 2024 May;13(5):e12433 [PMID: 38738585]
  46. JAMA. 2004 Oct 20;292(15):1845-52 [PMID: 15494582]
  47. Biomed Pharmacother. 2023 May;161:114557 [PMID: 36963364]
  48. Biomedicines. 2021 May 24;9(6): [PMID: 34073900]
  49. Aging (Albany NY). 2021 Jan 21;13(2):3060-3079 [PMID: 33479185]
  50. FASEB J. 2024 May 31;38(10):e23655 [PMID: 38767449]
  51. Front Med (Lausanne). 2024 Jul 30;11:1406547 [PMID: 39139783]
  52. J Am Soc Nephrol. 2017 Oct;28(10):2838-2844 [PMID: 28790143]
  53. Stem Cell Res Ther. 2020 May 27;11(1):206 [PMID: 32460853]
  54. J Extracell Vesicles. 2022 Mar;11(3):e12194 [PMID: 35230743]
  55. Cell. 2023 Jan 19;186(2):243-278 [PMID: 36599349]
  56. Cell Transplant. 2015;24(3):339-47 [PMID: 25622293]
  57. Eur J Pharmacol. 2023 Aug 5;952:175523 [PMID: 36736526]
  58. Am J Cancer Res. 2023 Dec 15;13(12):6270-6279 [PMID: 38187062]
  59. Heliyon. 2024 Sep 28;10(19):e38384 [PMID: 39430502]
  60. Acta Pharmacol Sin. 2024 Nov;45(11):2300-2312 [PMID: 38914677]
  61. ACS Biomater Sci Eng. 2020 Mar 9;6(3):1590-1602 [PMID: 33455380]
  62. Inflammation. 2024 Dec;47(6):2094-2107 [PMID: 38662165]
  63. J Nanobiotechnology. 2022 Oct 1;20(1):432 [PMID: 36183106]
  64. Nat Rev Nephrol. 2020 Jul;16(7):377-390 [PMID: 32398868]
  65. Front Endocrinol (Lausanne). 2021 Aug 12;12:711902 [PMID: 34456868]
  66. J Proteomics. 2025 Jan 6;310:105335 [PMID: 39433154]
  67. J Extracell Vesicles. 2024 Feb;13(2):e12404 [PMID: 38326288]
  68. Clin Orthop Relat Res. 2000 Mar;(372):139-50 [PMID: 10738423]
  69. Acta Neuropathol Commun. 2018 Dec 11;6(1):136 [PMID: 30537985]
  70. Nat Aging. 2023 Mar;3(3):327-345 [PMID: 37118429]
  71. Signal Transduct Target Ther. 2022 Aug 6;7(1):272 [PMID: 35933430]
  72. Sci Rep. 2017 May 31;7(1):2552 [PMID: 28566720]
  73. Adv Drug Deliv Rev. 2016 Feb 1;97:4-27 [PMID: 26562801]
  74. Nat Aging. 2021 Dec;1(12):1148-1161 [PMID: 35665306]
  75. Int J Nanomedicine. 2020 Aug 11;15:5911-5926 [PMID: 32848396]
  76. Trends Endocrinol Metab. 2024 Aug 23;: [PMID: 39181730]
  77. Cytotherapy. 2021 Jan;23(1):88-99 [PMID: 33097415]
  78. Ageing Res Rev. 2020 Jul;60:101063 [PMID: 32272170]
  79. Aging Cell. 2024 Oct 27;:e14390 [PMID: 39462849]
  80. Drug Deliv Transl Res. 2024 Jan;14(1):143-157 [PMID: 37540334]
  81. Regen Med. 2020 Apr;15(4):1561-1578 [PMID: 32479211]
  82. Neurobiol Dis. 2024 Oct 15;201:106683 [PMID: 39343249]
  83. J Biol Chem. 2014 Jun 13;289(24):16699-710 [PMID: 24753250]
  84. Stem Cell Res Ther. 2024 May 20;15(1):144 [PMID: 38764077]
  85. Biomedicines. 2024 Jan 03;12(1): [PMID: 38255205]
  86. Int Immunopharmacol. 2021 Jan;90:107010 [PMID: 33333415]
  87. Front Cell Dev Biol. 2022 Jan 20;9:808905 [PMID: 35127723]
  88. Stem Cells Transl Med. 2024 Mar 15;13(3):193-203 [PMID: 38366909]
  89. Biochem Pharmacol. 2019 Jul;165:49-65 [PMID: 30853397]
  90. Exp Mol Med. 2022 Sep;54(9):1390-1400 [PMID: 36138197]
  91. Life Sci. 2024 Nov 15;357:123047 [PMID: 39260518]
  92. Int J Nanomedicine. 2024 Apr 13;19:3555-3575 [PMID: 38638364]
  93. Int J Mol Sci. 2023 May 17;24(10): [PMID: 37240246]
  94. Sci Rep. 2023 Sep 11;13(1):14975 [PMID: 37697034]
  95. Stem Cells Int. 2021 Dec 3;2021:5548630 [PMID: 34899919]
  96. FASEB J. 2018 May 21;:fj201800059R [PMID: 29782203]
  97. J Control Release. 2024 May;369:335-350 [PMID: 38519036]
  98. Stem Cell Res Ther. 2022 Jul 16;13(1):322 [PMID: 35842714]
  99. Theranostics. 2021 Mar 11;11(11):5248-5266 [PMID: 33859745]
  100. Regen Ther. 2022 Aug 24;21:216-224 [PMID: 36092502]
  101. Signal Transduct Target Ther. 2024 Feb 5;9(1):27 [PMID: 38311623]
  102. J Dent Res. 2024 Oct;103(11):1057-1065 [PMID: 39272215]
  103. J Transl Med. 2024 Aug 5;22(1):722 [PMID: 39103873]
  104. Apoptosis. 2023 Aug;28(7-8):997-1011 [PMID: 37000316]
  105. Biomater Sci. 2019 Jun 25;7(7):2920-2933 [PMID: 31090763]
  106. Pharmacol Res. 2023 Jan;187:106607 [PMID: 36509316]
  107. Stem Cell Res Ther. 2019 Aug 14;10(1):250 [PMID: 31412919]
  108. Stem Cells Transl Med. 2019 Mar;8(3):215-224 [PMID: 30592390]
  109. Exp Cell Res. 2023 Jun 1;427(1):113566 [PMID: 37004949]
  110. Stem Cell Res Ther. 2023 May 29;14(1):146 [PMID: 37248536]
  111. Lancet. 2021 Apr 24;397(10284):1577-1590 [PMID: 33667416]
  112. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045 [PMID: 28522654]
  113. Stem Cell Res Ther. 2022 Jul 28;13(1):378 [PMID: 35902882]
  114. Biomaterials. 2022 May;284:121486 [PMID: 35447404]
  115. Stem Cell Res Ther. 2024 Sep 2;15(1):272 [PMID: 39218946]
  116. FASEB J. 2024 Apr 15;38(7):e23599 [PMID: 38572590]
  117. Cell Death Dis. 2020 Apr 27;11(4):288 [PMID: 32341347]
  118. Neural Regen Res. 2023 Oct;18(10):2291-2300 [PMID: 37056150]
  119. Nat Aging. 2024 Nov;4(11):1562-1581 [PMID: 39266768]
  120. Stem Cell Res Ther. 2013 Apr 25;4(2):34 [PMID: 23618405]
  121. Parkinsonism Relat Disord. 2024 Oct;127:107087 [PMID: 39142905]
  122. Annu Rev Physiol. 2018 Feb 10;80:27-48 [PMID: 28934587]
  123. Biochem Biophys Res Commun. 2022 Dec 3;632:195-203 [PMID: 36240643]
  124. Genomics. 2022 May;114(3):110319 [PMID: 35227836]
  125. Sci Rep. 2024 Mar 12;14(1):5959 [PMID: 38472335]
  126. Lancet. 2019 Jun 29;393(10191):2636-2646 [PMID: 31171417]
  127. Front Endocrinol (Lausanne). 2022 Jan 14;12:822294 [PMID: 35095776]
  128. Colloids Surf B Biointerfaces. 2024 Nov;243:114135 [PMID: 39106630]
  129. ACS Nano. 2018 Aug 28;12(8):7613-7628 [PMID: 30052036]
  130. IUBMB Life. 2019 Dec;71(12):2020-2030 [PMID: 31433911]
  131. Stem Cell Res Ther. 2022 Jun 17;13(1):258 [PMID: 35715841]
  132. Curr Stem Cell Res Ther. 2024 Feb 14;: [PMID: 38357953]
  133. Sci Rep. 2023 Jul 28;13(1):12240 [PMID: 37507448]
  134. Acta Biochim Biophys Sin (Shanghai). 2021 Aug 31;53(9):1166-1176 [PMID: 34254638]
  135. Trends Pharmacol Sci. 2024 Apr;45(4):350-365 [PMID: 38508958]
  136. Genes (Basel). 2020 Dec 23;12(1): [PMID: 33374593]
  137. J Biochem Mol Toxicol. 2024 Jan;38(1):e23624 [PMID: 38229323]
  138. Aging (Albany NY). 2023 Jul 18;15(14):6921-6932 [PMID: 37466443]
  139. J Zhejiang Univ Sci B. 2024 May 15;25(5):422-437 [PMID: 38725341]
  140. Heliyon. 2024 Sep 28;10(21):e38698 [PMID: 39559240]
  141. Exp Gerontol. 2023 May;175:112142 [PMID: 36921675]
  142. Cytokine Growth Factor Rev. 2023 Dec;74:40-55 [PMID: 37798169]
  143. Aging Cell. 2020 Nov;19(11):e13245 [PMID: 33029858]
  144. Bioact Mater. 2024 Aug 06;41:455-470 [PMID: 39188379]
  145. Signal Transduct Target Ther. 2024 Apr 23;9(1):102 [PMID: 38653983]
  146. Nat Cell Biol. 2023 Mar;25(3):415-424 [PMID: 36797475]
  147. Stem Cell Rev Rep. 2022 Mar;18(3):933-951 [PMID: 34169411]
  148. Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228 [PMID: 29339798]
  149. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1357-1366 [PMID: 30977425]
  150. Stem Cells Transl Med. 2024 Aug 16;13(8):803-811 [PMID: 38913985]
  151. Biochem Biophys Res Commun. 2022 Dec 20;635:194-202 [PMID: 36279681]
  152. Int J Nanomedicine. 2024 Sep 14;19:9575-9596 [PMID: 39296939]
  153. Cell Metab. 2020 Jul 7;32(1):71-86.e5 [PMID: 32574561]
  154. J Nanobiotechnology. 2023 Jun 12;21(1):188 [PMID: 37303049]
  155. Mol Ther. 2018 Dec 5;26(12):2838-2847 [PMID: 30341012]
  156. Int J Ophthalmol. 2021 Dec 18;14(12):1828-1833 [PMID: 34926195]
  157. Int J Biol Macromol. 2024 Aug;274(Pt 2):133420 [PMID: 38925194]
  158. Cell Commun Signal. 2023 Jun 19;21(1):146 [PMID: 37337219]
  159. Cells. 2024 Oct 07;13(19): [PMID: 39404421]
  160. Cell Death Dis. 2020 May 7;11(5):327 [PMID: 32382019]
  161. Breast Cancer. 2021 Jul;28(4):829-837 [PMID: 33770377]
  162. Cell. 2016 Dec 15;167(7):1719-1733.e12 [PMID: 27984723]
  163. Signal Transduct Target Ther. 2021 Jan 27;6(1):31 [PMID: 33500391]
  164. Int J Surg. 2024 Sep 5;: [PMID: 39236098]
  165. ACS Nano. 2023 Jul 25;17(14):13358-13376 [PMID: 37439514]
  166. J Nanobiotechnology. 2022 Jan 20;20(1):38 [PMID: 35057811]
  167. Tissue Eng Regen Med. 2024 Aug;21(6):897-914 [PMID: 38842768]
  168. J Extracell Vesicles. 2024 Nov;13(11):e70012 [PMID: 39508411]
  169. J Chem Neuroanat. 2022 Dec;126:102181 [PMID: 36330881]
  170. Front Endocrinol (Lausanne). 2024 Aug 12;15:1429567 [PMID: 39188913]
  171. Front Endocrinol (Lausanne). 2023 Jul 26;14:1205901 [PMID: 37564988]
  172. J Nanobiotechnology. 2024 Sep 20;22(1):583 [PMID: 39304945]
  173. J Neurosurg. 1988 Mar;68(3):352-7 [PMID: 3343606]
  174. Stem Cell Res Ther. 2023 Apr 7;14(1):66 [PMID: 37024925]
  175. Life Sci. 2023 Jun 1;322:121621 [PMID: 37001803]
  176. Stem Cell Res Ther. 2021 Jul 15;12(1):407 [PMID: 34266502]
  177. Lancet Neurol. 2021 May;20(5):385-397 [PMID: 33894193]
  178. Med Sci Monit. 2018 Dec 20;24:9272-9281 [PMID: 30571669]
  179. J Mater Sci Mater Med. 2023 Aug 28;34(9):43 [PMID: 37639051]
  180. Exp Cell Res. 2024 Apr 15;437(2):114009 [PMID: 38537745]
  181. Cell Mol Life Sci. 2020 Mar;77(5):937-952 [PMID: 31312880]
  182. Stem Cell Res Ther. 2021 Mar 24;12(1):204 [PMID: 33761997]
  183. Signal Transduct Target Ther. 2024 Oct 30;9(1):294 [PMID: 39472581]
  184. Sci Bull (Beijing). 2024 Dec 30;69(24):3978-3999 [PMID: 39455324]
  185. Int J Mol Sci. 2023 Apr 25;24(9): [PMID: 37175537]
  186. Cell Transplant. 2021 Jan-Dec;30:9636897211057465 [PMID: 34814742]
  187. Theranostics. 2024 Jun 24;14(10):3927-3944 [PMID: 38994017]
  188. Stem Cell Res Ther. 2022 Sep 5;13(1):449 [PMID: 36064647]
  189. Signal Transduct Target Ther. 2024 Jan 12;9(1):17 [PMID: 38212307]
  190. Small. 2020 Jan;16(3):e1906273 [PMID: 31840420]
  191. Annu Rev Physiol. 2018 Feb 10;80:309-326 [PMID: 29068765]
  192. Int J Mol Sci. 2024 May 17;25(10): [PMID: 38791505]
  193. Viruses. 2023 Oct 15;15(10): [PMID: 37896871]
  194. Biomedicines. 2022 Jul 27;10(8): [PMID: 36009357]
  195. Mol Ther. 2020 Feb 5;28(2):490-502 [PMID: 31818691]
  196. Int J Mol Sci. 2022 Nov 23;23(23): [PMID: 36498960]
  197. Cytotherapy. 2018 Jan;20(1):29-44 [PMID: 28943243]
  198. Nat Biotechnol. 2024 Jan;42(1):109-118 [PMID: 37106037]
  199. Med Res Rev. 2024 May;44(3):919-938 [PMID: 38095832]
  200. Stem Cell Res Ther. 2023 Sep 19;14(1):257 [PMID: 37726853]
  201. CNS Neurosci Ther. 2023 Aug;29(8):2236-2258 [PMID: 36890626]
  202. J Nanobiotechnology. 2024 Mar 21;22(1):124 [PMID: 38515095]
  203. ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18472-18487 [PMID: 33856781]
  204. Biomaterials. 2021 Dec;279:121185 [PMID: 34808560]
  205. Int Immunopharmacol. 2021 Dec;101(Pt B):108234 [PMID: 34655847]
  206. Annu Rev Biomed Eng. 2023 Jun 8;25:363-385 [PMID: 37289554]
  207. Cell Biol Toxicol. 2020 Apr;36(2):165-178 [PMID: 31820164]
  208. ACS Omega. 2023 Mar 08;8(11):10030-10039 [PMID: 36969465]
  209. Rejuvenation Res. 2021 Aug;24(4):283-293 [PMID: 33607932]
  210. Stem Cell Res Ther. 2024 Apr 29;15(1):122 [PMID: 38679727]
  211. J Clin Med. 2023 Nov 16;12(22): [PMID: 38002750]
  212. Sci Transl Med. 2021 Jan 27;13(578): [PMID: 33504653]
  213. Aging (Albany NY). 2020 Dec 9;13(2):2231-2250 [PMID: 33318310]
  214. Lancet. 2010 Dec 18;376(9758):2096-103 [PMID: 21094997]
  215. ACS Nano. 2024 Mar 5;18(9):7046-7063 [PMID: 38381372]
  216. J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):915-929 [PMID: 36708027]
  217. World J Stem Cells. 2024 Apr 26;16(4):410-433 [PMID: 38690517]
  218. Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:322-332 [PMID: 30889706]
  219. Stem Cell Res Ther. 2022 Jul 26;13(1):352 [PMID: 35883161]
  220. Aging (Albany NY). 2023 May 23;15(10):4144-4158 [PMID: 37229651]
  221. Annu Rev Cell Dev Biol. 2014;30:255-89 [PMID: 25288114]
  222. Front Pharmacol. 2024 Mar 27;15:1349199 [PMID: 38601464]
  223. Reprod Biol Endocrinol. 2024 Oct 16;22(1):125 [PMID: 39415205]
  224. Neuroscience. 2024 Jun 21;549:1-12 [PMID: 38705349]
  225. Cell. 2003 Jun 13;113(6):703-16 [PMID: 12809602]
  226. Int J Nanomedicine. 2024 Oct 29;19:10941-10959 [PMID: 39493276]
  227. Cell Cycle. 2019 Dec;18(24):3491-3501 [PMID: 31709894]
  228. J Extracell Vesicles. 2021 Dec;10(14):e12175 [PMID: 34918479]
  229. Int Immunopharmacol. 2023 Feb;115:109732 [PMID: 37724958]
  230. J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C7-12 [PMID: 16631513]
  231. Aging (Albany NY). 2021 Apr 21;13(8):11542-11563 [PMID: 33882455]
  232. Front Cell Dev Biol. 2023 Aug 03;11:1215698 [PMID: 37601097]
  233. J Extracell Vesicles. 2016 Oct 31;5:32945 [PMID: 27802845]
  234. Aging (Albany NY). 2023 Jun 16;15(12):5514-5534 [PMID: 37335082]
  235. Nat Rev Nephrol. 2024 Sep;20(9):603-615 [PMID: 39025993]
  236. IUBMB Life. 2024 Dec;76(12):1154-1174 [PMID: 39082886]
  237. Bioact Mater. 2021 Mar 05;6(9):2999-3012 [PMID: 33732969]
  238. J Orthop Translat. 2024 Oct 02;49:23-36 [PMID: 39420945]
  239. J Ovarian Res. 2024 Apr 15;17(1):80 [PMID: 38622725]
  240. FASEB J. 2019 Feb;33(2):1695-1710 [PMID: 30226809]
  241. Diabetes Res Clin Pract. 2022 Aug;190:109861 [PMID: 35367521]
  242. Mol Cell Biochem. 2025 Jan;480(1):309-323 [PMID: 38459276]
  243. Trends Biotechnol. 2025 Jan;43(1):61-82 [PMID: 39227240]
  244. Aging Clin Exp Res. 2019 Jun;31(6):807-813 [PMID: 30982220]
  245. Biomater Res. 2016 Aug 05;20:21 [PMID: 27499886]
  246. Stem Cell Res Ther. 2022 Jul 28;13(1):373 [PMID: 35902972]

Grants

  1. 2021YFA1101500/the National Key Research and Development Program of China
  2. 81974221/National Natural Science Foundation of China
  3. 81974009/National Natural Science Foundation of China
  4. 92049119/National Natural Science Foundation of China
  5. 2022CFA019/Hubei Innovation Group Foundation

MeSH Term

Humans
Extracellular Vesicles
Mesenchymal Stem Cells
Umbilical Cord
Aging
Animals
Mesenchymal Stem Cell Transplantation

Word Cloud

Created with Highcharts 10.0.0EVsanti-agingyoungHUCMSC-EVsagingage-relatedorgansstemresearchmilieucellsExtracellularvesiclescell-derivedbloodcirculatingHumanumbilicalcordmesenchymaldisordersglobalissuepopulationsbecomeincreasinglyprominentthusdevelopmenttherapiesassurelongevitywellamelioratecomplicationsputhighagendahumoralsubstantiatedimpartyouthfulcharacteristicsagedheterogeneousgroupmembrane-limitedstructuresservecouriersproteinsgeneticmaterialregulateintercellularcommunicationnoteappearedindispensablecomponentprolonginglifespansindicatedmediatebeneficialeffectisolatedyoungestadultcellsourcespeculatedreproducefunctionpartiallyrevitalizenumerousoldanimalsRobustevidencesuggestedmuti-targettherapeuticagentscombatingalleviatingdegenerativeprovidecomprehensiveovervieweffectsbrainheartvasculaturekidneymuscleboneFurthermorecriticallydiscusscurrentinvestigationengineeringstrategiesintendingunveilfullpotentialfieldTherapeuticEfficacyPromiseUmbilicalCordMesenchymalStemCell-DerivedVesiclesAgingAge-RelatedDisordersextracellular

Similar Articles

Cited By